Quest (Moxidectin (equine)) is filed as Macrocyclic lactone antiparasitic. The sections below restate public label fields stored for this profile.
Treatment and control of large and small strongyles Treatment of encysted cyathostomins (including early and late larval stages) Control of bots
Binds glutamate-gated chloride channels in parasite nerve and muscle cells, causing sustained paralysis and death, including encysted stages.
Do not use in foals under 6 months of age or miniature horses weighing less than 300 lbs. Overdose can cause neurologic signs.
Specific contraindication data for this veterinary product may not be available in public databases. Consult your veterinarian before use.
Lip swelling (Occasional); Loose stools (Occasional with heavy parasite burden)
Oral gel administered at 0.4 mg/kg body weight.
Limited structured drug interaction data is available from public sources for this veterinary product. Consult your veterinarian about potential interactions with other medications.
According to its FDA label, Quest (Moxidectin (equine)) is approved for: Treatment and control of large and small strongyles. Treatment of encysted cyathostomins (including early and late larval stages). Control of bots For medical advice, please talk to your prescriber or pharmacist.
Quest (Moxidectin (equine)) belongs to the Macrocyclic lactone antiparasitic class of medications.
Not yet. As of the most recent FDA data we ingest, no A-rated generic equivalent is listed for Quest. Availability changes as patents expire.
Our ingest of the FDA label for Quest (Moxidectin (equine)) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Quest (Moxidectin (equine)) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Quest (Moxidectin (equine)) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA label lists Zoetis as a labeler/manufacturer of Quest (Moxidectin (equine)). Multiple firms may market generics of the same molecule.
The FDA label states: "Store at controlled room temperature." Follow the packaging insert for the authoritative guidance.
Loading full data from Know Your Drugs Institute…